← Retour à la une
États-Unis · Actualité générale · National Geographic

Rethinking How to Fight the World’s Deadliest Infection

Publié par National Geographic · États-Unis il y a 9 h
Rethinking How to Fight the World’s Deadliest Infection
Rethinking How to Fight the World’s Deadliest Infection · National Geographic

Résumé détaillé

Scientists still don't fully understand what protects people from tuberculosis. Could an overlooked part of the immune system finally lead to better vaccines?

Scientists still don't fully understand what protects people from tuberculosis. Could an overlooked part of the immune system finally lead to better vaccines?

When Mehak Khan told her mother she planned to focus her PhD research on tuberculosis, her mother was skeptical: “Who even gets that anymore?,” she asked.

It’s a common misperception that tuberculosis is a bygone illness. The reality is that it kills more than 1.2 million people per year, making it the deadliest infectious disease on Earth. But that’s not the only aspect of it that’s poorly understood.

For decades, scientists have struggled to develop a new vaccine for a disease that remains shrouded in mystery. TB is famously sneaky—the bacterium that causes it can hide inside human immune cells and actively subvert or evade the body’s defenses. The only licensed vaccine to combat it, Bacille Calmette-Guérin, or BCG, is more than 100 years old and is not reliably effective in adults. M72, the current frontrunner among newer vaccine candidates, is now in a 20,000-person Phase 3 trial. In an earlier trial, its efficacy was around 50 percent.

Historically, scientists assumed that T cells are the body’s main defense against intracellular bacteria like the one that causes tuberculosis. The role of antibodies—produced by B cells—was largely dismissed. “We had this very black and white view of what T cells do versus what B cells do,” says Khan, a biomedical researcher specializing in infectious disease immunology. “It was always thought that T cells are the only arm of immunity that would be important.”

But recently, researchers have gained a better understanding of the role that antibodies might play in protection. The problem has been that bacteria are genomically enormous—Mycobacterium tuberculosis alone encodes roughly 4,000 proteins, more than 40 percent of which are uncharacterized. Because of this, says Khan, “we never knew which antigens really matter from a vaccine development point of view.”

That might not be…

Us…

Début de l'article, extrait de National Geographic. Pour lire la suite, ouvrez l'article chez le média.

Lire l'article complet sur National Geographic Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.nationalgeographic.com)

À lire aussi